ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,465,050 | +19.8% | 1,445,000 | 0.0% | 0.01% | +16.7% |
| Q1 2024 | $3,728,100 | +11621.7% | 1,445,000 | +10486.1% | 0.01% | – |
| Q4 2022 | $31,805 | -79.6% | 13,650 | -65.9% | 0.00% | – |
| Q4 2021 | $156,000 | +56.0% | 40,014 | +33.9% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | -82.9% | 29,880 | -90.7% | 0.00% | -88.9% |
| Q2 2020 | $586,000 | +1262.8% | 322,225 | +662.8% | 0.01% | +800.0% |
| Q1 2020 | $43,000 | -68.6% | 42,243 | -35.8% | 0.00% | 0.0% |
| Q2 2019 | $137,000 | +104.5% | 65,848 | +395.1% | 0.00% | 0.0% |
| Q1 2018 | $67,000 | -2.9% | 13,300 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | +7.8% | 13,600 | +32.0% | 0.00% | 0.0% |
| Q3 2017 | $64,000 | +93.9% | 10,300 | -23.1% | 0.00% | 0.0% |
| Q4 2016 | $33,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
| RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
| Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
| Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
| ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
| PDT Partners, LLC | 66,965 | $489,000 | 0.02% |